Miltenyi Biotech Steps into Microscopy Market

Bielefeld, Germany 10/12/18—Miltenyi Biotec has acquired LaVision BioTec for an undisclosed amount. LaVision BioTec provides light-sheet and multiphoton microscopy solutions for life science labs. LaVision BioTec’s TriMScope is capable of simultaneous real-time and deep in vivo imaging. “By combining our expertise in cell analysis and innovative detection reagents with LaVision BioTec’s imaging know-how, we will develop pioneering analytical tools for biomedical research,” said Stefan Miltenyi, founder of Miltenyi Biotec.

A Miltenyi Biotech spokesperson told IBO that LaVision BioTec has 55 employees. Asked for an example of a specific application or workflow that will benefit from the combination of Miltenyi Biotec’s cell analysis systems and reagents and LaVision’s microscopes, she provided an example in the field of immunotherapy. “Miltenyi Biotec has a large antibody portfolio to characterize, for example, T cells and tumor cells. The cells can be stained with these antibodies and then be analyzed by imaging with the LaVision BioTec Instruments.” 

< | >